High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 3, 2010, Pages 645-650

  Nakayama, Hidetsugu ^a,b   Satoh, Hiroaki ^c   Kurishima, Koichi ^a,c   Ishikawa, Hiroichi ^a   Tokuuye, Koichi ^a,d  

^a Tsukuba Medical Center   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Conformal; Elective; Lung cancer; Node; Non small cell lung cancer; Stage III

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; PESTICIDE EFFECTS; RADIOTHERAPY;

CONFORMAL; ELECTIVE; LUNG CANCER; NODE; NON SMALL CELL LUNG CANCER;

THREE DIMENSIONAL;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL RATE; TREATMENT OUTCOME; CARCINOMA, NON-SMALL-CELL LUNG; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; JAPAN; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 77957189229     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.037     Document Type: Article

References (25)

1. R.O. Dillman, S.L. Seagren, and K.J. Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
2. T. Le Chevalier, R. Arriagada, and E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417 423
3. W.T. Sause, C. Scott, and S. Taylor Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 1995 198 205
4. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study J Clin Oncol 23 2005 5910 5917
5. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable Stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
6. P. Zatloukal, L. Petruzelka, and M. Zemanova Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study Lung Cancer 46 2004 87 98
7. R.S. Pritchard, and S.P. Anthony Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis Ann Intern Med 125 1996 723 729
8. C.A. Perez, M. Bauer, and S. Edelstein Impact of tumor control on survival in carcinoma of the lung treated with irradiation Int J Radiat Oncol Biol Phys 12 1986 539 547
9. J.A. Hayman, M.K. Martel, and R.K. Ten Haken Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial J Clin Oncol 19 2001 127 136
10. J.G. Rosenman, J.S. Halle, and M.A. Socinski High-dose conformal radiotherapy for treatment of Stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356
11. M.A. Socinski, D.E. Morris, and J.S. Halle Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable Stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation phase I trial J Clin Oncol 22 2004 4341 4350
12. M.A. Socinski, J.G. Rosenman, and M.J. Schell Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable Stage IIIA/B nonsmall cell lung carcinoma: A modified Phase I trial Cancer 89 2000 534 542
13. S.E. Schild, W.L. McGinnis, and D. Graham Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 1106 1111
14. J.D. Bradley, M.V. Graham, and S. Suzanne Phase I results of RTOG L-0117: A phaseI/II dose intesfication study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC J Clin Oncol 23 2005 636
15. A.S. Lichter, and T.S. Lawrence Recent advances in radiation oncology N Engl J Med 332 1995 371 379
16. G.H. Fletcher Clinical dose-response curves of human malignant epithelial tumours Br J Radiol 46 1973 1 12
17. M.K. Martel, R.K. Ten Haken, and M.B. Hazuka Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37
18. P.D. Maguire, L.B. Marks, and G.S. Sibley 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer J Clin Oncol 19 2001 705 711
19. M.A. Socinski, A.W. Blackstock, and J.A. Bogart Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in Stage III non-small-cell lung cancer: CALGB 30105 J Clin Oncol 26 2008 2457 2463
20. L.B. Marks, and L.R. Prosnitz Assessing the impact of elective regional radiotherapy on survival Cancer J Sci Am 5 1999 92 100
21. K.E. Rosenzweig, S. Sura, and A. Jackson Involved-field radiation therapy for inoperable non small-cell lung cancer J Clin Oncol 25 2007 5557 5561
22. J. Bradley, M.V. Graham, and K. Winter Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328
23. S. Senan, S. Burgers, and M.J. Samson Can elective nodal irradiation be omitted in Stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol Phys 54 2002 999 1006
24. S. Sim, K.E. Rosenzweig, and R. Schindelheim Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 51 2001 660 665
25. S. Senan, J. van Sornsen de Koste, and M. Samson Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer Radiother Oncol 53 1999 247 255